Intelligent Investor

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.440 0.03 (1.24%)

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$492 Becoming a substantial holder 26 Feb 2024 6:08PM $2.790 $2.440 $2.460 fallen by 12.54%
$492 1H24 Results - Investor Webinar 9 Feb 2024 11:35AM $2.920 $2.440 $2.460 fallen by 16.44%
$492 Change in substantial holding 8 Feb 2024 4:19PM $2.910 $2.440 $2.460 fallen by 16.15%
$492 Change in substantial shareholding from AEF 7 Feb 2024 11:44AM $2.855 $2.440 $2.460 fallen by 14.54%
$492 Notification regarding unquoted securities - ACL 29 Jan 2024 12:26PM $3.100 $2.440 $2.460 fallen by 21.29%
$492 Notification regarding unquoted securities - ACL 29 Jan 2024 12:19PM $3.110 $2.440 $2.460 fallen by 21.54%
$492 Notification regarding unquoted securities - ACL 23 Jan 2024 4:50PM $3.050 $2.440 $2.460 fallen by 20%
$492 Change of Director's Interest Notice 4 Jan 2024 5:09PM $2.860 $2.440 $2.460 fallen by 14.69%
$492 Ceasing to be a substantial holder for HLS 22 Dec 2023 5:16PM $2.820 $2.440 $2.460 fallen by 13.48%
$492 HLS: Expiry of Unsolicited ACL Offer 22 Dec 2023 11:56AM $2.815 $2.440 $2.460 fallen by 13.32%
$492 Notice of withdrawal of offer - Healius Limited 22 Dec 2023 9:04AM $2.830 $2.440 $2.460 fallen by 13.78%
$492 Notification regarding unquoted securities - ACL 20 Dec 2023 12:30PM $2.875 $2.440 $2.460 fallen by 15.13%
$492 Notification of cessation of securities - ACL 20 Dec 2023 12:28PM $2.875 $2.440 $2.460 fallen by 15.13%
$492 Notification regarding unquoted securities - ACL 20 Dec 2023 12:27PM $2.875 $2.440 $2.460 fallen by 15.13%
$492 HLS:ACCC Rejection&ACL Notice of Intention to Withdraw Offer 15 Dec 2023 2:46PM $2.900 $2.440 $2.460 fallen by 15.86%
$492 Intention to withdraw takeover offer for Healius 15 Dec 2023 9:24AM $2.920 $2.440 $2.460 fallen by 16.44%
$492 AXX:Accc opposes Australian Clinical Labs' proposed acquis 15 Dec 2023 9:11AM $2.920 $2.440 $2.460 fallen by 16.44%
$492 Takeover offer - Healius entitlement offer 21 Nov 2023 9:59AM $2.570 $2.440 $2.460 fallen by 5.06%
$492 Fourth Supplementary Bidder's Statement 9 Nov 2023 6:00PM $2.660 $2.440 $2.460 fallen by 8.27%
$492 AIC Proceedings 3 Nov 2023 9:36AM $2.640 $2.440 $2.460 fallen by 7.58%
$492 Extension of offer period - notice of variation 1 Nov 2023 9:38AM $2.690 $2.440 $2.460 fallen by 9.29%
$492 Takeover offer for Healius - extension of offer period 1 Nov 2023 9:01AM $2.690 $2.440 $2.460 fallen by 9.29%
$492 Becoming a substantial holder from AEF 31 Oct 2023 9:00AM $2.650 $2.440 $2.460 fallen by 7.92%
$492 2023 AGM results 23 Oct 2023 11:20AM $2.770 $2.440 $2.460 fallen by 11.91%
$492 2023 AGM - Chair and CEO Address 23 Oct 2023 8:19AM $2.710 $2.440 $2.460 fallen by 9.96%

26 - 50 of 569 results

Page 2 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.